CEO, FullContact
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
CEO of Project Foundry
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Co-Founder, Sakti3
Executive Partner, Sofinnova Ventures
Founder and Chairman, Sycamore Networks
Telkonet, a small Milwaukee-area energy management and connected devices company, said this week it had hired the investment bank Roth Capital Partners “to explore strategic alternatives” with the goal of maximizing shareholder value.
Jason Tienor, president and CEO of Telkonet (OTCMKTS:... Read more »
More than a year after the FDA rejected Amgen’s experimental osteoporosis drug due to safety concerns, the Thousand Oaks, CA, company has teed up a new application.
The Amgen (NASDAQ: AMGN) drug, romosozumab (Evenity), is an antibody treatment meant... Read more »
Humans have had a drastic physical evolution recently—one that has notably taken only a few years. While the evolution from hunched primates to homo sapiens took tens of millions of years, we needed only about a decade to develop an arched... Read more »
It’s time to catch up on Boston tech headlines. This week, we’re tracking acquisitions by Autodesk and DataRobot, a $100 million investment in upstart wireless Internet provider Starry, a new startup from Runkeeper co-founder Jason Jacobs, details about a stealthy autonomous... Read more »
Drug price changes typically happen either at the start of the calendar year or the beginning of the third quarter. Such changes are routine for many companies, but Pfizer took an unusual step this week by rolling back scheduled price increases... Read more »
Cobalt is one of the ingredients in a type of rare earth magnet that, along with other rare earth magnets like neodymium and dysprosium, can be found in electric motors, smartphone batteries, and other products that are popular among consumers and... Read more »
Semiconductor maker Broadcom, which ended its effort to buy competitor Qualcomm earlier this year, has a new target: New York-based business software maker CA Technologies.
The pair announced Wednesday that Broadcom (NASDAQ: AVGO), which moved its headquarters from Singapore... Read more »
Just weeks ago, the FDA approved the first ever medicine made from a derivative of marijuana, a drug from GW Pharmaceuticals for a rare form of epilepsy. Yet competition already looms from San Diego’s Zogenix, thanks to new data the Emeryville,... Read more »
In a sea of emerging tech venture funds, Glasswing Ventures is trying to stand out. The Boston firm announced today it has closed its debut investment fund at $112 million.
That’s bigger than the “micro-VC” funds of the past decade, but... Read more »
PactSafe, an Indianapolis startup focused on cloud-based contracting services, announced this week that it has raised a $5.5 million Series A investment round. The round was co-led by Houston, TX-based Mercury Fund and Salt Lake City’s Signal Peak Ventures,... Read more »
Mark Cummins wondered why online search engines could help you locate a landmark halfway around the world in a second but couldn’t tell him whether the corner store had a craft beer he liked.
That’s what led him to co-found Pointy... Read more »
Penrose Studios, which has been scoring film festival awards for its early productions in virtual reality and augmented reality, announced today it raised $10 million in a Series A fundraising round.
Among the new investors backing the San Francisco studio are... Read more »
Akcea Therapeutics (NASDAQ: AKCA) has beaten rival Alnylam Pharmaceuticals (NASDAQ: ALNY) to a first drug approval, getting the nod for its drug inotersen (Tegsedi) in the European Union.
Akcea and Alnylam, both of Cambridge, MA, are developing treatments... Read more »
Otsuka Pharmaceutical is expanding its pipeline and U.S. reach with an agreement to acquire Waltham, MA, clinical-stage drug developer Visterra for $430 million in cash.
The deal, announced Wednesday, comes nine months after Visterra closed a $46.7 million Series C round... Read more »
Catalina Kaiyoorawongs knows from experience how dire the student debt crisis has gotten in the United States.
She spent years addressing access to loans for fellow low-income and first-generation students in Florida as part of her advocacy work, calling financial aid... Read more »
[Updated 7/11/18 11:02 a.m. See below.] Two Wisconsin-based organizations that invest in startups have done away with an arrangement they made four years ago that was aimed at getting early-stage companies to move to—or stay in—the state, and create... Read more »
[Updated 7/11/18, 12:01 pm. See below.] Businesses have sunk a lot of money into software tools to analyze the reams of data they’re generating, in search of insights that might help them increase sales or cut costs.
But analytics... Read more »
BioCryst Pharmaceuticals is ending a plan to merge with Idera Pharmaceuticals and form a single company focused on rare diseases.
Durham, NC-based BioCryst (NASDAQ: BCRX) terminated the merger agreement on Tuesday following a meeting that saw shareholders vote overwhelmingly against... Read more »
Austin—The possibility that Dell might return to the public markets has been talked about for months, if not longer. It became more realistic in February, when the Round Rock, TX-based company told securities regulators it was considering a public offering... Read more »
Restaurant technology startup Toast has pulled in $115 million in a Series D venture funding round that the company says gives it a valuation of $1.4 billion.
That makes it Boston’s newest “unicorn”—a privately held company valued at more than $1... Read more »
This year’s bumper crop of Xconomy Award startup finalists cover a wide range of technologies and approaches, from microbiome and gene therapy to regenerative medicine and emerging areas like chromatin biology. Some are early stage, some are already in the clinic... Read more »
Gregor Diagnostics has raised $900,000 from investors as part of a seed funding round that the Madison, WI-based startup says will support its efforts to develop a new, at-home screening test for prostate cancer that it hopes will offer a more... Read more »
Providence Ventures shares its advice on making successful invest
Providence Ventures
Professor of Systems Biology, Columbia University
Managing Partner at Pappas Ventures
Co-Founder and CEO, DNAnexus
Executive Partner, Sofinnova Ventures
Managing Director, D.E. Shaw and Co., L.P.
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
